Biotechnology firm announces one-for-16 reverse stock split, effective December 30
Number of outstanding shares to reduce from ~153.3 mln to ~9.6 mln
As of last close, shares down 45.8% this year
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.